WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Review Journal for Medical Science and Pharma Professionals

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

World Journal of Advance Healthcare Research (WJAHR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , Cosmos Impact Factor , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , Scientific Journal Impact Factor (SJIF) , IFSIJ Measure of Journal Quality , International Scientific Indexing, UAE (ISI) (Under Process) , International Impact Factor Services (IIFS) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Academia , Scope Database , Research Publication Rating and Indexing , Doi-Digital Online Identifier , ISSN National Centre , Zenodo Indexing , International CODEN Service, USA , 

ISSN 2457-0400

Impact Factor  :  7.675

WJAHR Citation

  All Since 2020
 Citation  105  60
 h-index  4  4
 i10-index  3  2

News & Updation

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in WJAHR coming Issue.

  • WJAHR: New Impact Factor

    WJAHR Impact Factor has been Increased from  5.464 to 7.675 for Year 2026.

  • WJAHR: OCTOBER ISSUE PUBLISHED

    OCTOBER 2026 Issue has been successfully launched on1 OCTOBER 2026.

  • New Issue Published

    Its Our pleasure to inform you that, WJAHR October 2026 Issue has been Published, Kindly check it on https://www.wjahr.com/home/current_issues

Best Article Awards

World Journal of Advance Healthcare Research (WJAHR) is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.

Best Article of current issue

Download Article : Click here

Indexing

Abstract

DETERMINATION OF GENTAMICIN IN SOME SYRIAN PHARMACEUTICAL PRODUCTS BY A NEW VISIBLE SPECTROPHOTOMETRIC METHOD

Mohammed Nour Dabaa*, Dr. Mohammad Abou Saleh

ABSTRACT

A Simple and sensitive spectrophotometric method has been described for the assay of Gentamicin in pure form and pharmaceutical products. The proposed method was based on the oxidation of the studied drug by a known excess of cerium (IV) sulfate in acidic medium and estimating the unreacted oxidizing agent by adding a known amount of methyl orange in the same acid medium and measuring the absorbance of the resulted solution at λmax = 500 nm. Different variables affecting the reaction were studied and optimized. Beer’s law is obeyed in the concentration range of 10-250 μg/mL (R2 = 0.9999). The limit of detection (LOD) and limit of quantification (LOQ) were 2.52 µg/mL and 7.63 µg/mL respectively. The method was validated, with percentage recovery ranging from 99.26% to 101.34% and a relative standard deviation (RSD) of 3.07%. Precision was evaluated both intra-day and inter-day (over three days), yielding relative standard deviations (RSDs) of 2.11% and 2.16%, respectively. The robustness of the method was assessed, and percentage recovery ranged from 98.73% to 102.51%, with an RSD not exceeding 4.50%. Recovery of gentamicin from pharmaceutical formulations was investigated. The amount of added reference standard was determined using the developed method, and recovery was close to 100%, with a relative standard deviation (RSD) not exceeding 3.30%. The method was successfully validated and can be applied to the determination of Gentamicin in several Syrian pharmaceutical products.

[Full Text Article] [Download Certificate]